Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Enzymatic production of a protein or polypeptide
Patent
1982-12-02
1986-05-27
Wiseman, Thomas G.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Enzymatic production of a protein or polypeptide
435 2, 435 70, 435 91, 435240, 435241, 435811, 424101, C12P 2100, A01N 102, C12P 2102, C12P 1934, C12N 500, C12N 502, C01G 900
Patent
active
045915571
ABSTRACT:
A process and cellular system for producing soluble biological mediators, including cytokines, lymphokines, monokines and interferons, and mRNA therefor, from white blood cells is provided. The process involves treating white blood cells with a mitogenic or antigenic agent in the presence of a controlled amount of red blood cells. Increases in production of the soluble biological mediator, gamma interferon, on the order of 5 to 10 fold have been achieved by maintaining the ratio of red blood cells to white blood cells between 10 to 1 and about 50 to 1. The process is particularly useful in producing HuIFN-.gamma. with PHA-P.
REFERENCES:
patent: 4376821 (1983-03-01), Braude
patent: 4376822 (1983-03-01), Braude
patent: 4382027 (1983-05-01), Braude
patent: 4440675 (1984-04-01), Braude
Brawerman, "The Isolation of Messenger RNA from Mammalian Cells", Methods in Enzymology 30F:605 (1974).
Johnson, R. A. et al., "Augmentation of Phytohaemagglutinin Mitogenic Activity by RBS Membranes," Fed. Proc. 29: 370, 1970.
Yachnin, S., et al., Proceedings of the Fourth Annual Leucocyte Culture Conference, pp. 37-47, Jun. 1969.
Chang, T. W., et al., Journal of Immunology, vol. 128, Feb. 1982, pp. 585-589.
Georgiades, J. A., et al., Interferon: Properties and Clinical Uses, 1980, pp. 97-110.
Wheelock, E. F., National Cancer Institute Monograph 22, 1965, pp. 73-76.
Wheelock, E. F., Science, vol. 149, 1965, pp. 310-311.
Barkhan, P. and Ballas, A., Nature, vol. 200, (Oct. 12, 1963), pp. 141-142.
Epstein, L. B., Biology of the Lymphokines (ed. Cohen, S.), Academic Press, New York, 1979, pp. 458-459.
Hall, L. S. and Gordon, D. S., Journal of Immunological Methods, vol. 12 (1976), pp. 31-38.
Johnson, R. A., et al., Cellular Immunology, vol. 3, pp. 186-197 (1972).
Kenyon, R. H., et al., Infection and Immunity, (Dec., 1977), vol. 18, No. 3, pp. 840-846.
Kishimoto, R. A., et al., Infection and Immunity, (Jan., 1978), vol. 19, No. 1, pp. 194-198.
Kornfeld, S., et al., Proc. N.A.S., (1969), vol. 63, pp. 1439-1446.
Kornfeld, R., et al., The Jorunal of Biological Chemistry, vol. 215, No. 10, May 25, 1970, pp. 2536-2545.
Maddison, S. E., et al., Infection and Immunity, (Jul., 1979), vol. 25, No. 1, pp. 237-248.
Maddison, S. E., et al., The American Journal of Tropical Medicine and Hygiene, vol. 28, No. 6, Nov. 1979, pp. 955-961.
Michalowski, A., Third Annual Leucocyte Culture Conference, pp. 41-52.
Ruscetti, F. W., et al., The Journal of Immunology, (May, 1975), vol. 114, No. 5, pp. 1513-1517.
Tarnvik, A., Acta Path. Microbiol. Scand. Section B, vol. 78, pp. 733-740 (1970).
Tarnvik, A., Acta Path. Microbiol. Scand. Section B, vol. 79, pp. 635-640 (1971).
Tarnvik, A., Acta Path. Microbiol. Scand. Section B, vol. 79, pp. 588-594 (1971).
Tarnvik, A., et al., Acta Path. Microbiol. Scand. Section B, vol. 80, pp. 107-114 (1972).
Todd, C. W., et al., Transactions of the Royal Society of Tropical Medicine and Hygiene, (1981), vol. 75, No. 6, pp. 783-787.
Wallen, W. C., et al., Cellular Immunology, (1973), vol. 6, pp. 110-122.
Webb, P. J., et al., Cellular Immunology, (1980), vol. 52, pp.370-380.
Keyes Lynne D.
Testa Douglas
Interferon Sciences, Inc.
Martinell James
Pirri Vincent P.
Wiseman Thomas G.
LandOfFree
Process and materials for producing soluble biological mediators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process and materials for producing soluble biological mediators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process and materials for producing soluble biological mediators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1570979